CNS Pharmaceuticals
NASDAQ: CNSPHouston, US · Nevada corporation
CNS Pharmaceuticals is a biopharmaceutical company building a pipeline in neurology and oncology by acquiring or in-licensing preclinical and clinical-stage therapeutic assets. It focuses on programs targeting significant unmet medical needs with differentiated mechanisms of action.
Founders & leadership
RL
Rami LevinExecutive
SO
Steve O'LoughlinExecutive
Board
AM
Amy MaheryBoard director
JK
Jeffry KeyesBoard director
FC
Faith CharlesBoard director
MF
Michal FisherBoard director
BC
Bettina CockroftBoard director
Reported raises · per SEC filings
Form D private placements$22.5M disclosed across 1 round · 2026
▶$22.5MraisedMay 2026 · 13 investors · PharmaceuticalsRule 506(b)
▶$22.5MraisedMay 2026 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rami LevinExecutive Officer, Director
- Amy MaheryDirector
- Jeffry KeyesDirector
- Steve O'LoughlinExecutive Officer
- Faith CharlesDirector
- Michal FisherDirector
- Bettina CockroftDirector
- Offering amount
- $22.5M
- Amount sold
- $22.5M
- Sales commissions
- $1.6M
- Placement agents
- A.G.P./Alliance Global Partners
- First sale
- May 2026
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Robinhood32 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Cenexelresearch25 shared keywordsCenExel operates a clinical research network that conducts trials and studies for pharmaceutical and biotechnology companies developing new therapies. The company provides research centers, investigator expertise, and patient enrollment support to accelerate the clinical development process.
Companies competing with CNS Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
CNS Pharmaceuticals outlines pivot, $22.5M raise | CNSP 8-K Filingstocktitan.net · Jul 2026
CNS Pharmaceuticals (CNSP) registers 9.79M shares including prefunded warrantsstocktitan.net · May 2026
The Truth Behind CNS Pharmaceuticals Recent Stock Surgeharianbasis.co · May 2026CNS Pharmaceuticals raises $22.5M in private placement | CNSP 8-K Filingstocktitan.net · May 2026Frequently asked questions
- What does CNS Pharmaceuticals do?
- CNS Pharmaceuticals is a biopharmaceutical company building a pipeline in neurology and oncology by acquiring or in-licensing preclinical and clinical-stage therapeutic assets. It focuses on programs targeting significant unmet medical needs with differentiated mechanisms of action.
- How much funding has CNS Pharmaceuticals raised?
- CNS Pharmaceuticals has disclosed $22.5M raised across 1 round.
- Where is CNS Pharmaceuticals headquartered?
- CNS Pharmaceuticals is headquartered in Houston, US.